6 results match your criteria: "Federal Research Center Komi Scientific Centre[Affiliation]"
Antioxid Redox Signal
March 2024
Laboratory of Geroprotective and Radioprotective Technologies, Institute of Biology of the Federal Research Center "Komi Scientific Centre" of the Ural Branch of the Russian Academy of Sciences, Syktyvkar, Russia.
Currently, a large amount of evidence of beneficial effects of diets enriched with polyphenols on various aspects of health has been accumulated. These phytochemicals have a geroprotective potential slowing down the pathological processes associated with aging and ensuring longevity. In this study, a comprehensive analysis was conducted to determine the adherence of individual polyphenols to geroprotector criteria.
View Article and Find Full Text PDFAntibiotics (Basel)
December 2022
Institute of Fundamental Medicine and Biology, Kazan Federal University, 420008 Kazan, Russia.
Infectious diseases caused by various nosocomial microorganisms affect worldwide both immunocompromised and relatively healthy persons. Bacteria and fungi have different tools to evade antimicrobials, such as hydrolysis damaging the drug, efflux systems, and the formation of biofilm that significantly complicates the treatment of the infection. Here, we show that myrtenol potentiates the antimicrobial and biofilm-preventing activity of conventional drugs against and mono- and dual-species cultures.
View Article and Find Full Text PDFACS Appl Bio Mater
August 2021
Kazan Federal University, 420008 Kazan, Russian Federation.
Spectrochim Acta A Mol Biomol Spectrosc
March 2022
Kazan State Medical University, 49 Butlerova st., 420012 Kazan, Russia; Kazan Federal University, 18 Kremlevskaya st., 420008 Kazan, Russia.
Bull Exp Biol Med
July 2020
Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.
2,6-Diisobornyl-4-methylphenol (Dibornol, 10 mg/kg intragastrically daily for 5 days after myocardial ischemia/reperfusion) 1.5-fold increased rat survival during the acute post-infarction period in comparison with the control group. In survivors, Dibornol reliably prevented post-ischemic progression of heart failure in the delayed post-infarction period (30 days after ischemia/reperfusion), which was seen from an increase in the left-ventricular developed pressure by 22%, left-ventricular contractility index by 19%, and +dP/dt by 34%.
View Article and Find Full Text PDFBull Exp Biol Med
July 2020
Institute of Physiology, Federal Research Center Komi Scientific Centre, Ural Division of Russian Academy of Sciences, Moscow, Russia.
The effect of preventive administration of melatonin on the arrhythmogenic substrate in the myocardium was studied in the rabbit model of acute ischemia/reperfusion in vivo. The animals treated with melatonin 60 min before ischemia induction had shorter median activation time compared to the control group (p=0.039), less pronounced shortening of repolarization durations in the ischemic zone during coronary occlusion (p=0.
View Article and Find Full Text PDF